These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33339442)

  • 61. Downregulating vaccinia-related kinase 1 by luteolin suppresses ovarian cancer cell proliferation by activating the p53 signaling pathway.
    Chang X; Tamauchi S; Yoshida K; Yoshihara M; Yokoi A; Shimizu Y; Ikeda Y; Yoshikawa N; Kiyono T; Yamamoto Y; Kajiyama H
    Gynecol Oncol; 2023 Jun; 173():31-40. PubMed ID: 37075494
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of histone methyltransferase SETD8 represses DNA virus replication.
    Chen L; Yang C; Tang SB; Long QY; Chen JD; Wu M; Li LY
    Cell Insight; 2022 Jun; 1(3):100033. PubMed ID: 37193046
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MicroRNA-127-3p inhibits proliferation and invasion by targeting SETD8 in human osteosarcoma cells.
    Zhang J; Hou W; Chai M; Zhao H; Jia J; Sun X; Zhao B; Wang R
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1006-11. PubMed ID: 26707641
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Loss of BAP1 function leads to EZH2-dependent transformation.
    LaFave LM; Béguelin W; Koche R; Teater M; Spitzer B; Chramiec A; Papalexi E; Keller MD; Hricik T; Konstantinoff K; Micol JB; Durham B; Knutson SK; Campbell JE; Blum G; Shi X; Doud EH; Krivtsov AV; Chung YR; Khodos I; de Stanchina E; Ouerfelli O; Adusumilli PS; Thomas PM; Kelleher NL; Luo M; Keilhack H; Abdel-Wahab O; Melnick A; Armstrong SA; Levine RL
    Nat Med; 2015 Nov; 21(11):1344-9. PubMed ID: 26437366
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin.
    Driskell I; Oda H; Blanco S; Nascimento E; Humphreys P; Frye M
    EMBO J; 2012 Feb; 31(3):616-29. PubMed ID: 22117221
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis.
    Karagoz K; Mehta GA; Khella CA; Khanna P; Gatza ML
    EBioMedicine; 2019 Dec; 50():191-202. PubMed ID: 31767542
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ALDH1A3 contributes to tumorigenesis in high-grade serous ovarian cancer by epigenetic modification.
    Huang J; Tang Y; Li Y; Wei W; Kang F; Tan S; Lin L; Lu X; Wei H; Wang N
    Cell Signal; 2024 Apr; 116():111044. PubMed ID: 38211842
    [TBL] [Abstract][Full Text] [Related]  

  • 68. BDE-209 induced spermatogenesis disorder by inhibiting SETD8/H4K20me1 related histone methylation in mice.
    Li X; Zhang Y; Gao L; Yang X; Zhou G; Sang Y; Xue J; Shi Z; Sun Z; Zhou X
    Sci Total Environ; 2023 Mar; 864():161162. PubMed ID: 36572290
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.
    Ma H; Li Y; Wang X; Wu H; Qi G; Li R; Yang N; Gao M; Yan S; Yuan C; Kong B
    Cell Death Dis; 2019 Feb; 10(3):166. PubMed ID: 30778048
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 72. NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.
    Nakshatri H; Appaiah HN; Anjanappa M; Gilley D; Tanaka H; Badve S; Crooks PA; Mathews W; Sweeney C; Bhat-Nakshatri P
    Cell Death Dis; 2015 Jan; 6(1):e1608. PubMed ID: 25611383
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
    Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
    Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monomethyltransferase SETD8 regulates breast cancer metabolism via stabilizing hypoxia-inducible factor 1α.
    Huang R; Yu Y; Zong X; Li X; Ma L; Zheng Q
    Cancer Lett; 2017 Apr; 390():1-10. PubMed ID: 28089831
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
    Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W
    Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Function of m
    Yang S; Zhou D; Zhang C; Xiang J; Xi X
    Cancer Biol Ther; 2023 Dec; 24(1):2263921. PubMed ID: 37800580
    [TBL] [Abstract][Full Text] [Related]  

  • 77. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
    Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW
    Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer.
    De Donato M; Petrillo M; Martinelli E; Filippetti F; Zannoni GF; Scambia G; Gallo D
    Gynecol Oncol; 2017 Jul; 146(1):170-178. PubMed ID: 28495238
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers.
    Ciucci A; Zannoni GF; Buttarelli M; Lisi L; Travaglia D; Martinelli E; Scambia G; Gallo D
    Oncotarget; 2016 Feb; 7(7):8155-71. PubMed ID: 26797759
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.
    Chen H; Tu SW; Hsieh JT
    J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.